1. Blundell, J.E. and Hill, A.J., 1987, Influence of tryptophane on appetite and food selection in man. In: Amino Acids in Health and Disease: New Perspectives, Kaufman, S., ed., Alan R. Liss, New York, p. 403–419.
2. Borsini, E, Bendotti, L., Aleotti, A., Samanin, R., and Garattini, S., 1982 d-Fenfluramine and d-norfenfluramine reduce food intake by acting on different serotonin mechanisms in the rat brain, Pharmacol. Res. Comm.
14:671–678.
3. Campbell, B., Dard-Brunelle, B., and Caccia, S., 1997, The use of pharmacokinetics in the assessment of dexfenfluramine safety. In: Obesity Management and Redux™, Nicolaidis, S. ed. Academic Press, San Diego, p. 65–80.
4. Cheymol, G., Weissenburger, J., Poirier, J.M., and Gellee, C., 1995, The pharmacokinetics of dexfenfluramine in obese and non-obese subjects, Br. J. Clin. Pharmacol.
39:684–687.
5. Clausing, P., Newport, G.D. and Bowyer, J.F., 1998, Fenfluramine and norfenfluramine levels in brain microdialysate brain tissue and plasma of rats administered doses of d-fenfluramine known to deplete 5-hydroxytryptamine levels in brain, J. Pharmacol. Exp. Ther.
284:618–624.